Literature DB >> 26164816

Lowering the Floor on Trail Making Test Part B: Psychometric Evidence for a New Scoring Metric.

Stephen Correia1, David C Ahern2, Amanda R Rabinowitz3, Thomas J Farrer4, Ashley K Smith Watts4, Stephen Salloway5, Paul F Malloy6, Sean C L Deoni7.   

Abstract

The Trail Making Test Part B (TMT-B) is widely used in clinical and research settings as a measure of executive function. Standard administration allows a maximal time score (i.e., floor score) of 300 s. This practice potentially masks performance variability among cognitively impaired individuals who cannot complete the task. For example, performances that are nearly complete receive the same 300-s score as a performance of only a few moves. Such performance differences may have utility in research and clinical settings. To address this, we propose a new TMT-B efficiency metric designed to capture clinically relevant performance variability below the standard administration floor. Our metric takes into account time, correct moves, and errors of commission and omission. We demonstrate that the metric has concurrent validity, permits statistical analysis of performances that fall below the test floor, and captures clinically relevant performance variability missed by alternative methods. Published by Oxford University Press 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Keywords:  Alzheimer's disease; Executive function; Mild cognitive impairment

Mesh:

Year:  2015        PMID: 26164816     DOI: 10.1093/arclin/acv040

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  5 in total

1.  Episodic Memory Impairment Mediates the Loss of Awareness in Mild Cognitive Impairment.

Authors:  Geoffroy Gagliardi; Patrizia Vannini
Journal:  Front Aging Neurosci       Date:  2022-01-21       Impact factor: 5.750

2.  Motor-Independent Cognitive Testing in Motor Degenerative Diseases.

Authors:  Henning Schmitz-Peiffer; Elisa Aust; Katharina Linse; Wolfgang Rueger; Markus Joos; Matthias Löhle; Alexander Storch; Andreas Hermann
Journal:  J Clin Med       Date:  2022-02-03       Impact factor: 4.241

3.  Automated Early Detection of Alzheimer's Disease by Capturing Impairments in Multiple Cognitive Domains with Multiple Drawing Tasks.

Authors:  Masatomo Kobayashi; Yasunori Yamada; Kaoru Shinkawa; Miyuki Nemoto; Kiyotaka Nemoto; Tetsuaki Arai
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

4.  Endovascular treatment improves cognition after stroke: A secondary analysis of REVASCAT trial.

Authors:  Elena López-Cancio; Tudor G Jovin; Erik Cobo; Neus Cerdá; Marta Jiménez; Meritxell Gomis; María Hernández-Pérez; Cynthia Cáceres; Pere Cardona; Blanca Lara; Arturo Renú; Laura Llull; Sandra Boned; Marian Muchada; Antoni Dávalos
Journal:  Neurology       Date:  2016-12-09       Impact factor: 9.910

5.  Progressive multiple sclerosis, cognitive function, and quality of life.

Authors:  Helene Højsgaard Chow; Karen Schreiber; Melinda Magyari; Cecilie Ammitzbøll; Lars Börnsen; Jeppe Romme Christensen; Rikke Ratzer; Per Soelberg Sørensen; Finn Sellebjerg
Journal:  Brain Behav       Date:  2018-01-05       Impact factor: 2.708

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.